Newspapers don’t usually report on suicide cases for fear of copycats.

Woman’s online journal of disorder paves way for new medical courses

http://www.kpaddock.org/

 

Apparently most newspaper editors are totally disconnected from the fact that the USA has 40,000 – 50,000 suicide every year and ONE MILLION ATTEMPTS.

Robert Paddock is a quiet man with a single mission in life – to tell the story of his late wife’s struggle with chronic pain and raise awareness of her illness.

He also wants people to know her suicide wasn’t meaningless. That she lives on.

Robert describes Karen as his “best friend,” and was devastated when she ultimately lost her battle with her daily, debilitating headaches and committed suicide on Aug. 7, 2013.

When Robert approached the newspaper, he wanted someone to write about his wife’s suicide. An editor explained to him that newspapers don’t usually report on suicide cases for fear of copycats. But Robert was humbly insistent.

“Her case is something different,” Robert said.

And it was.

“My name is Karen Shettler Paddock. I am dead. I committed suicide on August 7, 2013, as I could no longer stand the excruciating headache caused by a Intracranial Hypotension, more commonly known as a Cerebrospinal Fluid (CSF) Leaks. A condition that is more common that many think (for example Actor George Clooney had a CSF Leak and considered suicide), yet is so unknown that some doctors argue the condition does not even exist,” reads the opening page of Karen’s online journal.

Robert has made it his personal mission to help others by maintaining Karen’s online journal. Karen wrote for more than 20 years about her life with chronic, debilitating headaches and struggle to find a diagnosis. Her illness became so severe that she saw no other way to relieve her pain than to take her own life.

Yet out of this tragedy, some hope has arisen.

Instructors at the Duke University of Medicine are using Karen’s journal, found at http://www.kpaddock.com, as a case-study to teach students how to recognize the symptoms of a Cerebrospinal Fluid (CSF) Leak, the rare disease that Karen suffered from.

Karen’s journal has also inspired those suffering with chronic pain across the globe. Many people have already personally reached out to Robert to know that Karen’s story has helped them – some were considering suicide and sought treatment after reading Karen’s journal. Others were able to recognize their symptoms and get tested for a CSF Leak after hearing about her struggles.

Karen’s first-hand account of her illness gave an honest, heart-wrenching depiction of what it is like to live with debilitating pain day-to-day.

One of the most baffling symptoms of her illness is that Karen’s headaches would go away when she was lying down, only to return when she stood up for any length of time.

“CSF is a very misunderstood condition because when you’re lying down you feel better. When you wake up in the morning your brain is full of fluid and your muscles are relaxed which plugs the leaks,” Robert said.

“You want to get up and get on with your life. But a few hours later, this debilitating headache comes back. Because of this, it’s sometimes called an ‘afternoon headache’,” he added.

Karen felt that many of her friends and family did not understand her condition, and it lead to her feeling extremely isolated from everyone but her husband and beloved dogs.

“People that have not experienced severe unrelenting pain for months or years expect you to suck it up and continue your normal daily activities. Chronic pain makes you feel alone. Like no one understands how much pain you are in,” wrote Karen Paddock in her online journal.

Karen went from doctor to doctor seeking a diagnosis for her symptoms and for years heard that she was healthy and only seeking attention.

“Many of those doctors told her that ‘it was all in her head’ or that she was making up her symptoms to get attention,” Robert said.

Yet her headaches continued.

Karen saw more than 35 different doctors who were unable to give her a proper diagnosis or provide relief from the pain she experienced.

“My depression is from the pain I feel, too. I think sometimes, that if we do not fit the typical symptoms that doctors learned about in medical school, that they blame our problems on us. Like they think it is all our fault,” Karen wrote.

In her frustration, Karen began researching on her own.

“She became a huge supporter of the Franklin Library. As far as book-based learning goes, she could have gotten a doctorate in her condition,” Robert said.

Eventually, Karen’s contact with the outside world became extremely limited. In addition to Robert and her pets, Karen tried to interact online a few hours a day with others who suffered with chronic pain. When building Karen’s website, Robert poured through emails and more than 9,437 Facebook private messages to compile a 20-year medical history of Karen’s struggles with her CSF Leak.

Eventually, a specialist in Pittsburgh was able to give Karen a proper diagnosis. But her body ultimately rejected the spinal patches that were supposed to provide her with relief. Only four doctors in the world specialize in treating CSF Leak, and Robert believes we don’t know enough about the illness to properly treat it long-term.

“Research into such leaks is only about 10 years old We just don’t know enough on how to treat CSF Leak without causing rebound pressure issues that cause the exact same excruciating headaches,” Robert said.

In an effort to learn more, Robert is trying to set up a $750,000 Fellowship program at Duke to train more doctors and fund better research equipment that will locate CSF Leaks sooner. Those who would like to donate can do so through http://www.kpaddock.com

When asked how he dealt with Karen’s death, Robert turns the conversation back to Karen’s story. His ultimate goal is that her story be told and help others.

On her last day, Karen wasn’t just having a headache. Her symptoms included issues with her vision, nausea, dizziness and hearing. She spoke to her next-door neighbor earlier in the day, and he said that she appeared fine. Robert says that chronic pain sufferers often learn to mask their pain so well that they will continue smiling on the outside, even though they feel horrendous inside.

Robert still misses Karen every day. She was the love of his life, and his constant companion. Without her, he says he feels an ache in his heart that will never go away.

He is determined not to let others take the path that Karen chose to take.

“I tell them not to do this, that if we don’t raise awareness of their illness and pain no one will ever know when they need help,” Robert said.

Opioid Rxs decline 20%… Opioid OD deaths at record levels in Ohio

Opioid Prescriptions In Ohio Continue To Decline

http://radio.wosu.org/post/opioid-prescriptions-ohio-continue-decline

Who believes that politicians/bureaucrats will come to the conclusion anytime soon that they come to the realization that legal prescription opiates are not a major part of the problem. I VOTE NO!!!

As the number of opioid-related deaths in Ohio remains high, the number of prescriptions dropped for the fourth straight year.  

The State Board of Pharmacy reports that between 2012 and 2016, the total number of opioids prescribed to Ohio patients dropped by 162 million doses. That’s about a 20 percent decline.

At its peak, that number reached 793 million doses. The report also found a 78 percent decrease since 2012 in the number of people engaged in the practice of doctor-shopping, meaning going to multiple doctors in order to receive additional prescriptions.

In 2014, however, Ohio had the highest number of deaths from opiate overdoses in the country, according to the Kaiser Family Foundation.

State mental health official Tracy Plouck says Ohio has one of the most comprehensive approaches to address the opioid prescription crisis.

The State Board of Pharmacy began in 2006 to collect information on all prescriptions for controlled substances that pharmacies dispense.

Bill would allow juveniles involved in non-violent pharmacy robberies to be tried as adults

Bill would allow juveniles involved in non-violent pharmacy robberies to be tried as adults

http://www.theindychannel.com/news/politics/bill-would-allow-juveniles-involved-in-non-violent-pharmacy-robberies-to-be-tried-as-adults

INDIANAPOLIS — State lawmakers are considering a plan that would allow teens to be prosecuted for robbing pharmacies.

Senator Michael Young said the number of pharmacy robberies must be addressed in the new session of legislature, and he believes his bill will help with that.

Right now, unless a juvenile uses a gun or commits bodily injury during a robbery their crime can’t be waived to adult court. But with Sen. Young’s bill, that would change.   

“What we’re trying to do is to take away the incentive of these kids who know what they are gonna do very little time and get $1,500 to $2,500 for these robberies,” said Young.

But not everyone agrees with Young.  Indiana Black Expo president Tanya Bell thinks juveniles should be tried as juveniles, as long as there was no extreme violence.

“Let the juvenile courts handle it. They are better equipped to handle it. Let them treat them and let them handle it. They do not belong in adult court if they are unarmed and if there is no bodily injury.” said Bell.

In 2015, Indianapolis led the nation in pharmacy robberies. That dropped in 2016, as major chains started installing time-released safes.

Indiana is still second in the country for pharmacy robberies, only California has more. 

 

Maryland Opioid Epidemic: New Laws Tackle Addiction

Maryland Opioid Epidemic: New Laws Tackle AddictionMaryland Opioid Epidemic: New Laws Tackle Addiction

http://patch.com/maryland/annapolis/maryland-opioid-epidemic-new-laws-tackle-addiction

Last year for the first time deaths from the use/abuse of Alcohol exceeded 100,000 a 20% increase over 2015 and abt 450,000 from the use/abuse of the drug Nicotine… those two drugs killed more people in a SINGLE YEAR that all the USA soldiers killed in the 12-14 yr Vietnam War and the four year World War II.. IN 2016, we had between 40,000 – 50,000 suicides and abt ONE MILLION ATTEMPTS. As a society… no mourning those deaths… no front page headlines… no part of the judicial system focusing on those deaths. It is claimed that prescription opiates are the gateway drug to Heroin use/abuse.. what is the gateway drug that leads to an addiction to the two drugs Alcohol and Nicotine ?

ANNAPOLIS, MD — Maryland’s governor on Tuesday proposed new legislation aimed at fighting the state’s opioid addiction crisis. But the personal story of Anne Arundel County’s top prosecutor illustrates two of the issues that contribute to the problem: physicians who prescribe heavy-duty painkillers when they may not be needed, and red tape that complicates efforts by families to get someone into a treatment program, and then keep them there.

The press conference led by Gov. Larry Hogan Hogan was held at Anne Arundel Medical Center in Annapolis. Hogan said that he did not fully appreciate the scope of the opioid epidemic until he began traveling around Maryland during his gubernatorial campaign three years ago. He said when he asked people across the state what their community’s biggest problem was, regardless of whether they were from a rural, urban, wealthy, or poor community, “the answer was always the same: heroin.”

State’s Attorney Wes Adams, R-Anne Arundel, spoke about the recent death of his brother-in-law, who he said died of an opioid overdose. Adams said his brother-in-law became addicted to opioids after being prescribed painkillers following a surgery about eight years ago. He said he moved in and out of rehab centers and periodically became clean, only to relapse later.

Adams noted the obstacles from the medical and insurance industries that he and his family faced as they tried to keep his brother-in-law in treatment. He also expressed consternation over recently being prescribed a substantial supply of Oxycontin, an opioid pain-killer, following a medical procedure, despite telling his doctor that he was only experiencing moderate pain.

He said that the only major side-effect his pharmacist warned him of was constipation, despite the well-documented risk of addiction that use of the drug carries.

Experts say that many heroin users in the state are people who became addicted to prescription narcotics following an injury or surgery, then begin to use cheaper illicit heroin when they can no longer obtain prescriptions for legal opioids.New Legislation Targets Addiction Crisis

Lt. Gov. Boyd Rutherford — whom the governor has directed to focus on opioid addiction — said the governor would sign an executive order that will create an Opioid Operations Command Center, a “virtual” task force charged with organizing training and funding for local anti-addiction teams, as well as collecting data on opioid use and abuse.

Both Hogan and Rutherford appeared optimistic but acknowledged that the problem of opioid addiction is worsening in Maryland. Anne Arundel County Executive Steve Schuh said that, at the start of his tenure a couple years ago, there was one overdose per day and one death per week from opioid abuse in his county. He said those figures have risen to two overdoses per day and two and a half deaths per week.

Proposed legislation includes:

The Prescriber Limits Act would prevent doctors from prescribing more than seven days worth of opioid painkillers during a patient’s first visit or consultation. The law exempts patients going through cancer treatment and those diagnosed with a terminal illness.

The Distribution of Opioids Resulting in Death Act would introduce a new felony charge carrying up to 30 years in prison for people convicted of illegally selling opioids or opioid analogues that result in the death of a user. Rutherford said the law would carry protections for people who were selling to support their addiction.

And the Overdose Prevention Act authorizes the collection of and review of non-fatal overdose data and would make it easier for people to fill prescriptions for naloxone, a drug that can counteract the effects of an opioid overdose.

Drug Treatment Plan

Hogan’s proposed fiscal year 2018 budget includes $4 million in new spending to increase support for those struggling with heroin and opioid addiction. In addition, the budget contains $1.3 billion for mental health and substance use disorders, including $159 million dedicated to existing non-Medicaid substance use disorder treatment programs.

In addition, the Maryland Department of Health and Mental Hygiene recently received a Medicaid waiver renewal for its HealthChoice Program. This will allow Maryland Medicaid to reimburse for residential substance use treatment services delivered in large facilities, known as Institutes for Mental Diseases, greatly expanding the number of facilities in Maryland that can offer treatment services.

This waiver will also authorize the state to pursue presumptive eligibility for people leaving jail or prison through its Medicaid State Plan. In the coming weeks the state will amend its Medicaid State Plan to create this eligibility option, which will supplement Maryland Medicaid’s current jail enrollment and care coordination strategy.

— Story By JACOB TAYLOR, Capital News Service, with additional reporting by Patch Editor Deb Belt; file photos of Anne Arundel County State’s Attorney Wes Adams and Maryland Gov. Larry Hogan

 

Chuck Rosenberg Will Stay On as Head of the DEA

Chuck Rosenberg Will Stay On as Head of the DEA

You know, the guy who said medical marijuana was a joke!

https://www.merryjane.com/news/chuck-rosenberg-will-stay-on-as-head-of-the-dea

Here is a previous posts about Rosenberg

Rosenberg is “an example of an inept, misinformed zealot who has mismanaged America’s failed policy of marijuana prohibition

Seven lawmakers signed a letter delivered to the White House Thursday, “Mr. Rosenberg is not the right person to lead the DEA.”

It has been reported that Rosenberg is a recovered ALCOHOLIC… do we really need a recovered ALCOHOLIC in charge of the DEA ?  We have seen how people who have lost relatives to substance abuse… will the beliefs of a recovered alcoholic be that much difference ?  Is he going to look at enforcing CSA laws through a BIASED LENS ?

When it comes to enforcing control on the substances being distributed throughout the nation, the Trump Administration is picking up where former President Obama left off by putting its faith in the work of DEA Administrator Chuck Rosenberg.

Earlier last week Press Secretary Sean Spicer confirmed that Rosenberg would stay on as the head of the U.S Drug Enforcement Administration. In an interview with NPR, Spicer said the decision to keep Rosenberg and a number of other Obama staffers was in the interest of keeping the government fully functional as President Trump breaks in his new seat in the Oval Office.

Unfortunately, this does not give the marijuana reform community much hope of seeing any significant changes to the current Schedule I listing of the cannabis plant. After all, it was Rosenberg who made the call last year not to downgrade marijuana to a lesser classification. The nation’s leading drug enforcer said the “decision isn’t based on danger. This decision is based on whether marijuana, as determined by the FDA, is a safe and effective medicine… and it’s not.”

But then again Rosenberg has never really had much faith in the concept of the cannabis plant healing the sick.

“What really bothers me is the notion that marijuana is also medicinal — because it’s not,” Rosenberg told CBS News. “We can have an intellectually honest debate about whether we should legalize something that is bad and dangerous, but don’t call it medicine — that is a joke.”

However, science begs to differ.

Last week, the National Academies of Sciences, Engineering and Medicine, which consists of the nation’s leading scientific authorities, published a detailed report entitled “The Health Effects of Cannabis and Cannabinoids,” which states that the cannabis plant does, in fact, have medicinal properties.

The report, which pulled from around 24,000 scientific studies, found marijuana shows promise in the treatment of chronic pain and nausea. But it did go on to say that there is not enough evidence to support it as a cure for cancer or treatment for epilepsy.

Researchers blame the federal government’s willingness to keep marijuana bound by its Schedule I classification for jamming up scientific progress with respect to further studies.

“There is a clear need to establish what is known and what needs to be known about the health effects of cannabis use,” the report concludes.

Did you hear that Rosenberg?

 

TAG…. you’re it !! THE BALL IS IN YOUR COURT !

It was reported today that the State of Maine has implemented “cookie cutter opiate dosing”… I expect that just like the CDC guidelines… prescribers and various healthcare entities will state that they are implementing these new guidelines and they will IGNORE the pts that are exempt from these limits.

You can’t successfully sue the state… the only thing that you can do is challenge the constitutionality of the law.  But by the time that the challenge crawls thru the courts… most/all medical practices will have implemented this law as their practice’s policies and procedures and makes the constitutionality of law a mute issue.

I recently blogged about how class action lawsuits can probably be brought against corporate entities (large medical practices, hospitals, insurance companies) who profess to be implementing these guidelines and laws Regain your quality of life … SUE THEIR ASS !

The politicians and bureaucrats are going to continue to pass these opiate dosing limitations and in all likelihood those corporate entities will implement portion of the guidelines while ignoring the exceptions that are in place to help make sure that legit chronic pain pts get proper therapy.

In that above post is a link to a website that lists 85 class action law firms. A class action law suit only needs one LEAD PLAINTIFF … everyone else just goes along for the ride.

These class action law firms goes after entities that have done harm to large number of people and have “deep pockets”… They work on a per-cent of the WINNINGS… (contingency basis)

But unless someone being HARMED contacts them… they will not even be aware of what is being done to millions of chronic pain pts.

None of the healthcare providers ( Pharmas, Prescribers, Pharmacies, Pharmacists, Hospitals) are going to take a stand… the DEA controls their ability to stay in business because they controls their licenses. The insurance companies are going to save money – generate more profits – by following enforcing these guidelines.

YOU (chronic pain pts) are combatants in the war on drugs – like it or not !!  IMO, until the CDC guidelines and other states have implemented laws… the chronic pain pts… were getting screwed and didn’t have the mental, physical, financial capability to level the playing field.

Now that healthcare corporation are adopting the most stringent portions of these guidelines/laws and ignoring the exceptions where chronic pain pts can be properly treated and forcing/mandating that their employed prescribers follow the corporation’s  cookie cutter policies and procedures on opiate dosing.. could have created a whole new playing field.

Getting a number of class action law suits against these corporations may cause other legislators to take a pause in passing more of these laws and other corporations from going down the same path as other corporations have taken… and so far gotten away with it… The CDC guidelines were implemented March 2016.  The one year anniversary maybe the correct timing to start going after those corporations who have decided to practice medicine without a license and NOW maybe the appropriate time for individual chronic painers to start contacting these class action law firms… the more chronic painers they hear from the more likely it will get their attention and cause to action.

THE BALL IS IN YOUR COURT !

Maine’s politicians decided to become “the doctor” for all pts suffering from pain

Central Maine patients fear weaning off opioids as they struggle with chronic pain

http://www.centralmaine.com/2017/01/21/central-maine-patients-fear-medication-weaning-as-they-struggle-with-chronic-pain/

If the doctors in Maine read the law and observe the exceptions to the daily mgs limits… chronic pain pts will be properly treated… Pts entitled to palliative care is exempt from this limits and the definition of palliative care is defined within Maine’s statues:

§ 1726.  Palliative Care and Quality of Life Interdisciplinary Advisory Council

The Palliative Care and Quality of Life Interdisciplinary Advisory Council, as established in Title 5, section 12004-I, subsection 47-I and referred to in this section as “the advisory council,” is established to improve the quality and delivery of patient-centered and family-focused care in accordance with this section.

1.  Definitions.   As used in this section, unless the context otherwise indicates, the following terms have the following meanings.

A.  “Palliative care” means patient-centered and family-focused medical care that optimizes quality of life by anticipating, preventing and treating suffering caused by a medical illness or a physical injury or condition that substantially affects a patient’s quality of life, including, but not limited to, addressing physical, emotional, social and spiritual needs; facilitating patient autonomy and choice of care; providing access to information; discussing the patient’s goals for treatment and treatment options, including, when appropriate, hospice care; and managing pain and symptoms comprehensively.
B.  “Serious illness” means a medical illness or physical injury or condition that substantially affects quality of life for more than a short period of time. “Serious illness” includes, but is not limited to, Alzheimer’s disease and related dementias, lung disease, cancer and heart, renal or liver failure.

New state law aimed at combating the growing opiate crisis includes limits on prescription medication, raising fears about quality of life and the role of legal drugs as treatment.

As John Nichols tries to go about his daily life, he aches and his knees and hips hurt, among other daily pains.

“It feels like someone is stabbing a knife in my neck and it’s stuck in there, and every time I move it gets stabbed,” he said, describing his daily pain level as a 7 on a scale of 1 to 10.

 

A few months ago, his pain was at level 3. He could still do the simple things he needs to do to live his life — mow his lawn, do his dishes or go fishing with his son. Nichols, 50, of Winslow, is one of many patients with chronic pain who fear the worst as they are weaned off their opiate medications by their doctors: the loss of quality of life.

“You think I want to lay on the couch my whole life?” Nichols said. “I’m really scared.”

Now he and thousands of others like him are bracing for the pain while the effects of a new state law take hold. The law aims to reduce the amount of medication that can be prescribed to patients, with some exceptions, as the state grapples with a growing opiate abuse epidemic. At the same time, some central Maine patients on opiate medication for chronic pain treatment say they shouldn’t be punished for others’ illegal drug use with new medication limits, and even some medical professionals fear the short-term effects of the law.

And while patients concerned about medication limits may be able to qualify for exceptions, two of the people interviewed weren’t aware of exceptions and already were being tapered off their medications by doctors. Another said there’s scant information available about how to apply and qualify.

L.D. 1646, introduced by Gov. Paul LePage during the 2016 session, is meant to prevent opiate abuse and bolster prescription monitoring to prevent people from “doctor shopping.”

Limiting prescriptions is among the most controversial aspects of the bill, called “An Act to Prevent Opiate Abuse by Strengthening the Controlled Substances Prescription Monitoring Program.” New patients are limited to a dosage amount of less than 100 morphine milligram equivalents, or MME, of opiates, and those already taking medications above the limit must taper to less than 100 MME by July 1. Medical professionals measure opiates by morphine milligram equivalents to figure out corresponding dosages of different medications.

Meanwhile, there’s a growing body of evidence that using opioid medication to treat chronic pain is worse for patients over the long term, but those already using such treatment now might have no other choice.

The Maine Medical Association worked with the LePage administration to compromise on some aspects of the bill and ensure there would be exceptions for patients who need high dosages of the medications. A number of doctors have said they understand that something needed to be done to curb the growing opiate epidemic, but some still wish measures could have been taken without legislation.

“I hate having medicine legislated,” said Steve Diaz, chief medical officer for MaineGeneral Medical Center in Augusta. “I believe as a profession we physicians should be policing ourselves and have the wherewithal to provide guidelines. But I think the issue here is the opioid epidemic was getting worse, and there was no national or state medical response to rein it in.”

However, raising awareness about the exceptions is another hurdle the association will have to jump to ensure patients, possibly like Nichols, can get the help they need.

The legislation also limits the amount of opiates that can be prescribed for daily use as well how much can be supplied within a certain period. A patient can’t be prescribed more than a 30-day supply of opioids for chronic pain treatment, or a seven-day supply for acute pain treatment. It also requires prescribers who have the capability to prescribe all opiates electronically to do so.

The Prescription Monitoring Program will require prescribers to check prescription monitoring information for a patient’s records at the initial time of prescribing an opioid and every 90 days afterward, unless it is in a hospital or facility setting. Prescribers also must complete three hours of education on opioid medication prescribing every two years.

About 16,000 patients in Maine are prescribed more than 100 morphine milligram equivalents, according to Gordon Smith, executive vice president of the Maine Medical Association. About 1,300 Maine patients are prescribed more than 300 MME.

“Even at 200 morphine milligram equivalents, you have a 1 in 32 chance of dying within the next two-and-a-half years,” Smith said. “That’s a mortality rate that’s very, very high.”

According to the state attorney general’s office, Maine had 286 drug overdose deaths in 2016 through Sept. 30, exceeding the 272 deaths in all of 2015. Most of those deaths were fueled by the opioid epidemic.

MAKING EXCEPTIONS

The Maine Medical Association, a statewide organization aimed at supporting Maine physicians as well as the health of the state’s citizens, ultimately backed L.D. 1646 after the LePage administration agreed to lengthen the maximum supply for prescriptions. A number of exceptions also are included in the legislation.

Smith, the association’s executive vice president, said he thinks there are enough exceptions to account for nearly every patient’s situation.

Physicians can prescribe opioid medication above the new legal limit for pain related to cancer treatment, end-of-life care, treatment for substance abuse and palliative care. Palliative care, as defined by state law, is patient-centered care that aims to optimize quality of life by anticipating and treating “suffering caused by a medical illness or physical injury or condition.”

Patients suffering from chronic pain, such as those who talked with the Morning Sentinel, most likely could qualify for the palliative exception, but it’s unclear how they would go about qualifying for it. Nichols said his doctor hasn’t talked with him about finding a way to keep his normal dosages, and it’s unclear if patients would be able to qualify for an exception without a doctor’s cooperation or effort.

Kate Carll, 60, of Hallowell, was taking up to 1,200 morphine milligram equivalents of methadone in one day after a back surgery eight years ago and other injuries left her with severe, chronic pain in her back, legs and feet. Her doctor, James Wilson at MaineGeneral Physiatry, now has switched her to a different opiate painkiller, oxymorphone, and lowered her dosage to 20 milligrams, or 60 MME, per day. A MaineGeneral spokeswoman said the health care system would not be able to discuss individual patients, even with that patient’s permission.

“I can’t be on more than 20 milligrams a day — that’s breakfast food,” Carll said. “I understand the law. I totally understand what they were trying to do, but it’s going to make it worse. I’m going to end up in a nursing home, and as a result, they’re spending more money on me.”

Because her new dose is not strong enough, Carll said, she has had increasing difficulty walking. She now uses a cane and has a hunch in her back. She doesn’t think she would ever look to street drugs to help with the discomfort, but worries she’ll eventually be confined to a wheelchair and a nursing home.

So Carll did some research and found the palliative care exception, she said, determining that she could qualify, and her doctor agreed to work with her to get the exception.

“That was not offered to me; that was because I dug,” she said.

However, she said it’s not clear yet what the process will be. Carll will get the paperwork to start the process and sign a contract, and at the end her doctor will be able to prescribe her medication up to a “therapeutic level,” though she said that probably won’t be at the level she was at before. Carll also said she’s afraid a lot of people with chronic pain will “fall through the cracks” and either won’t realize there’s an exception or won’t be offered a chance to use it.

Samantha Edwards, spokeswoman for the Department of Health and Human Services, did not respond to multiple requests for comment on the law and the palliative care exception.

Smith, from the Maine Medical Association, said paperwork shouldn’t be involved for those who qualify for the exception. However, he also acknowledged that it’s been difficult to raise awareness about the exceptions, even in the medical community.

“One would hope that the providers and the patients work together,” Smith said. If not, there is the option of going to a different provider, but he acknowledged that “very few people in the current environment are very enthusiastic” about patients with severe chronic pain.

The new law won’t be enforced until a much later date, he said. For the prescription monitoring component, enforcement will begin March 1. The state will begin enforcing opioid limits as late as October.

This gives patients, their families and prescribers the opportunity to attend public hearings and argue for more exceptions.

Diaz, the chief medical officer for MaineGeneral, said the new law has the potential to help because it gives doctors a way to talk with patients about alternatives. However, he said the bill could become a “double-edged sword.”

“If we can become compliant, the number of deaths from opiates should decrease,” Diaz said, but patients also could have trouble tapering their opioid usage and turn instead to street drugs such as heroin to ease the pain.

PATIENT PAIN

Nichols, the Winslow patient, broke his neck in an accident when he was 25. He had surgery 15 years ago to have four discs taken out, but the operation wasn’t done correctly, he said, and the screws in his neck were broken.

The failed operation is what started the horrible pain Nichols still is dealing with, and it’s what started his years of opioid use.

A doctor in Augusta first prescribed him four 15-milligram morphine pills each day, along with four 10-milligram methadone pills. That combination has a morphine milligram equivalent of 380 milligrams.

“I was doing great,” he said. His pain level was at a 3.

Then Nichols’ doctor quit, and his new doctor took him off the morphine medication, he said, and is tapering him off the methadone pills, without much of an explanation.

He’s now down to 3.5 10-milligram methadone pills per day, which has a morphine equivalent of 280 milligrams.

Nichols is among several patients in central Maine who fear effect of the new law.

Jeff Miller, 54, of Albion, said he started taking methadone about five years ago.

Miller was in a snowmobile accident in 1997, breaking his left ankle, hip, elbow, heel, both his scapulae and his nose. The accident also broke six of his ribs and compressed some of his vertebrae. At first he was prescribed Percocet for the pain. He never wanted to start taking methadone, but it was recommended because of its longer release time, he said.

Miller was taking nine 10-milligram methadone pills per day in the late summer, which equals 1,080-milligram morphine equivalents, and now has been tapered to less than five 10-milligram pills per day.

Now he’s afraid he’ll return to the same level of pain he had after the accident.

“I’m going to start back where I was, and I’m going to have a craving for this stuff,” Miller said. “What are we going do?”

Both Miller and Nichols worry that as their medication is lowered to comply with the new legislation, they’ll be forced to go out on the street to get something to help the pain.

“I understand that there’s a heroin epidemic, but it has nothing to do with us decent people who are in pain,” Miller said. “They don’t have an epidemic yet.”

Smith, of the Maine Medical Association, said that “help is coming” for those who are tapering off. Nurse practitioners and physician assistants can prescribe suboxone, a narcotic that is used to treat addiction to pain relievers, beginning in February. The Maine Department of Health and Human Services also announced $2.4 million in funding used to create 359 additional medication-assisted treatment slots across the state that began Jan. 1. The department plans to provide more slots in the Down East and western areas of the state.

NOT THE BEST FORM OF TREATMENT

While the use of opioid medication for chronic pain may be common, it’s not necessarily the best form of treatment. A growing body of evidence shows that long-term opioid use actually worsens chronic pain, as well as depression, ability to function and overall quality of life, said Dr. Stephen Hull, director of medical pain management at the Mercy Pain Center in Portland.

As a pain doctor, Hull was a regular prescriber of high dose opioids until he became increasingly dissatisfied with the outcomes he was observing in his patients. When he attended a conference on the effectiveness of opioids held by the federal Food and Drug Administration and Centers for Disease Control and Prevention, Hull was confronted by an array of studies showing that chronic opioid patients routinely reported worse pain and more diminished ability to function than patients who did not take opioids. Patients on higher opioid dosages also reported worse symptoms than those on lower dosages. Those results make sense when you look at how opioids affect the body, Hull said.

“They work very well for dampening down activity of the nervous system in relationship to pain,” Hull said. But the drugs also activate the immune system within the brain and spinal cord, making the brain more sensitive to pain. So although opioid patients experience short-term pain relief, the activation of the immune system results in even higher pain levels as the drug leaves the bloodstream. At the same time, as patients build up tolerance to the drugs, they require higher and higher dosages to feel the positive effects and stave off the heightened pain levels that come with withdrawal.

Hull said since he moved away from prescribing opioids he is seeing better outcomes for his patients.

“What we’ve seen at the Mercy Pain Center is that those folks who are willing to come off these medicines succeed at high rates and report not only that their pain is better but that their cognitive functioning is much better,” Hull said. “We’ve come to feel that not only is it appropriate to get under that 100 milligram equivalents of morphine, we are telling our patients that it’s appropriate to get them off opioids altogether.”

Even with these observations, Hull said he plans to testify in coming months in favor of exemptions for patients who are unsuccessful in their efforts to get off opioids. Long-term opioid use alters the structure of the brain in ways that sometimes might be irreversible, Hull said. Even in studies of patients who wanted to kick the drugs, 10 percent to 12 percent were unable to do so.

“The 10 to 12 percent may have the misfortune of having persistent changes to their brains that’s going to make them lifelong dependents on opioids,” Hull said. “To be compassionate we need to have some exceptions for patients who at the very least have made a concerted effort of getting off opioids.”

In practice, Hull expects that patients who are less open to getting off the drugs will be less successful in their attempts, increasing the number of patients who might qualify for the exemption.

Dr. Kristen Silvia, a family physician at Maine Medical Partners in the Scarborough Family Medicine Office, also expressed concern about the addictive nature of opioids. Up to one-third of patients can get addicted to the drugs, which often comes with side effects such as nausea or constipation. They also can have long-term health effects on cognitive function, Silvia said.

“We have been taught that opioid medications were good,” Silvia said. “We’re a victim of the drug companies who said they were safe.”

Within her own practice, Silvia has tapered most of her patients off opioids, she said. To treat chronic pain, she takes a more “patient-centered, comprehensive” approach, looking at the patient’s mental health, diet and sleep habits in addition to his or her physical state.

Silvia echoed a frustration with health insurers as well, saying that there are often limits to what they will cover, which can prohibit patients from trying alternatives, such as physical therapy or acupuncture.

“We, as a medical community, need to advocate more for our patients and get some of these alternative treatments better reimbursed,” she said.

One of Silvia’s patients, Noreen Alton-Jones, 60, of Standish, uses opioid medication for intense pain from sciatica, which runs along the sciatic nerve. Alton-Jones was prescribed 150 pills per month — and took up to 10 of those 5-milligram oxycodones with acetaminophen per day, which is about a 75-milligram morphine equivalent, for about eight months.

“My pain tolerance is pretty high,” Alton-Jones said. “Oxycodone was the only thing that would keep (the pain down) so I could actually get up and move around.”

But she’s tapered down her medications, from getting 150 pills each month to 20. The tapering sometimes gives her what she called the “heebie-jeebies,” a jittery feeling. She takes tizanidine, a muscle relaxant, when that happens.

Alton-Jones attributes much of her success in tapering to her doctors, whom she said she was “lucky” to find.

“You’re always going to be in pain, and a lot of people can’t handle that, you know? It’s like having a dull toothache,” Alton-Jones said. “I wanted to get off them, and maybe that makes a difference.”

An ‘insurance warrior’ fights to get pricey therapies covered

An ‘insurance warrior’ fights to get pricey therapies covered

https://www.statnews.com/2016/04/25/insurance-warrior/

Her name is passed from one desperate family to another like an amulet.

In phone conversations and online chat rooms, she’s mentioned at moments when the devout might call on a patron saint. A baby born with a deformed skull? “Call Laurie.” An impossibly expensive cancer treatment? “Call Laurie.”

Laurie Todd isn’t a doctor, or a lawyer, or a hospital chaplain. She’s a 66-year-old former massage therapist. Most of the time, she sounds cheerful and efficient. But if someone tries to pull the wool over her eyes, her voice gets low and a little bit threatening. “Do you know what I do for a living?” she asks. “I’m known as the Insurance Warrior.”

The military metaphor is apt. When a health insurance company refuses to pay for a medical procedure, Todd goes to battle on behalf of the patient from her apartment outside Seattle.

She researches the scientific evidence behind the treatment. She parses the fine print of insurance policies. She scours the internet for the home phone numbers of the company’s top executives, and she coaches her clients on when to call and what to say. Her strategy seems to be working: By her own count, she has won 165 of the 169 cases she’s fought.

“I’m sitting here in my pajamas making decision-makers who get $20 million a year do the right thing,” she said.

There are all sorts of reasons insurers might deny coverage: They might call a treatment experimental, or say it’s not medically necessary, or insist that a local doctor in their network do the work, rather than a distant expert.

Many health economists argue that insurers are right to deny coverage of some procedures in order to reduce America’s astronomical health care costs. But even they agree with Todd about one thing: the system is so hard to navigate that the typical patient feels powerless when facing denials.

“Health insurance is completely byzantine,” said George Loewenstein, an economist at Carnegie Mellon University. “Even insurance executives themselves … have trouble making sense of the monster they’ve created.”

That’s where Todd comes in.

“I would be a widow if not for her,” said Diana Lentz.

“I am a story person. This work puts me at the epicenter of the world’s best stories”

Laurie Todd, the Insurance Warrior

 

When Lentz’s husband, Matthew, was diagnosed with cancer, their insurance company would only pay for his surgery if he went to a local surgeon who had little experience with the procedure he needed. The Lentzes wrote an appeal themselves, demanding that Matthew be treated by a true expert. It was rejected. They enlisted Todd’s help with a second version. It, too, was rejected.

Only when Todd and the Lentzes gave speeches to a board room full of insurance executives and lawyers was the coverage approved.

Todd can speak legalese and knows her way around statistics, but she attributes her success to her master’s in 18th-century French literature. Her appeals can run 55 pages, and they interweave technical arguments with vivid details that make the patient’s story come alive.

“I wouldn’t win them if I took a legal approach. I win them because I take a literary approach,” she said. “I am a story person.  This work puts me at the epicenter of the world’s best stories.”

Reversing a death sentence

Todd wrote poems as a child. She studied French, and because she was good at languages, her guidance counselor told her to become a teacher. She did. She didn’t like it much.

So she moved from state to state, taking jobs here and there, as a file clerk for a computer manufacturer, as a secretary for companies that sold everything from cookies to phones, insurance to medical devices. In California, she tried her hand at real estate, but it wasn’t her cup of tea.

Todd was working as a massage therapist in Seattle when she fell ill in October 2004. First, she noticed the exhaustion: She started feeling dog tired even before she put her hands on a patient’s back.

Then she realized her belly was getting bigger.

“I would be a widow if not for her.”

Diana Lentz, wife of cancer patient

 

She went to a doctor who said she was fine. But her symptoms kept getting worse, and in March 2005, she was diagnosed with late-stage ovarian cancer and rushed into surgery.

That diagnosis wasn’t right either. It turned out she had appendix cancer, and it had spread into her abdominal cavity, creating tumors so voluminous that there was still plenty left inside her after 15 pounds were scooped out during the emergency operation.

Her oncologist told her there was no treatment. She decided to do her own research.

“The first place I went was PubMed, where all the scientific articles reside,” she said. “What I learned was that there’s lots and lots of science about appendix cancer. And I learned that there was a certain surgeon in Washington, D.C., who stood head and shoulders above the rest.”

But her insurance company would not pay for him to operate because he was out-of-network. From an insurer’s perspective, contracting with certain hospitals allows them to keep the price for each service reasonable.

From Todd’s perspective, though, the insurance company’s decision seemed like a death sentence. She knew this surgery was as intricate as defusing a bomb, and she’d seen research showing that a surgeon only got the best outcomes after performing the surgery at least 150 times.

She’d gone to see the in-network surgeon her insurance company recommended, and she wasn’t impressed: “I said, ‘How many of these surgeries have you done?’ and he goes, ‘Six.’ And I said, ‘How are your patients doing?’ He said, ‘Don’t know, don’t follow ‘em.’ And I said, ‘Thank you very much, I’m out of here.’”

Todd went ahead and booked her surgery in D.C. But she was in a bind. She was self-employed, and she was too sick to work. She had almost no money.

Even without complications, her surgery could cost hundreds of thousands of dollars.

“I wasn’t going to die because my insurance company refused to pay,” she said. And so she set about writing an appeal.

“Where do you start with a strategy game? You study your opponent,” she said.

She read the insurance company’s entire website. She created a flow chart of the organization, listing its CEO, and its vice presidents, and its board members. She went to the public library, sat on the floor, and read everything they had on insurance law. She reviewed every article she could find on appendix cancer. Then she began to write.

“Treatments are denied with words,” she said. “And denials are overturned with words.”

She estimates that her entire hospital stay cost $347,000 — and her insurance company paid for everything but $9.

A warrior in purple flannel PJs

The surgery was like getting hit by a bus, Todd said. She was in the hospital for 43 days. When she came back to Seattle, she couldn’t climb the stairs to her apartment.

“It’s like a tsunami had swept everything away: who I was before, my work, my stamina. I had no idea what was going to happen next,” she said.

What happened next was a phone call, out of the blue, from a man named Bob. He had appendix cancer, and he needed the same surgery she’d just had. His insurance company was refusing to pay for it, not because it was out-of-network, but because they said the procedure was experimental. He’d heard from an appendix cancer support group that Laurie had just won an appeal. Could she help him?

She had nothing else to do. Using her appeal as a template, she wrote a document for Bob. “He called me three days later, and he said, ‘Laurie, they are going to pay.’ And my joy was immense.”

Bob’s was the first of 20 appeals she wrote that year, mostly sitting at home in her purple flannel pajamas. At first, her clients were all appendix cancer patients, referred to Todd by other families.

As she started ringing up wins, her confidence grew. In 2007, she wrote a how-to book and traveled the nation to speak at Rotary Clubs and cancer conferences. Soon she was getting calls from other kinds of patients. She only took on the ones, she said, that had “a mountain of science” behind them.

“He said, ‘Laurie, they are going to pay.’ And my joy was immense.”

Laurie Todd

 

By then, she was charging for her services and earning a living writing appeals. Todd won’t talk about her fees, but former clients usually paid between $1,000 and $2,000.

“Best $2,000 I ever spent,” said Lisa Frank of Anaheim, Calif.

Her daughter had a severe form of Tourette’s that resisted treatment. The tics came on with such violence that when she was 13, she fractured her own hip. But the tics just kept coming, the constant spasms preventing the bone from knitting back together. The pain, Frank said, made her daughter suicidal.

The insurance company wouldn’t pay for the experimental deep-brain stimulation that some doctors recommended.

“Initially, Laurie came off kind of clinical. She’s not overly friendly,” said Frank. But Todd won her over with a single question: What do you think “experimental” means? Frank gave her a definition. “No,” Todd said, “that’s not what experimental means. It means whatever your insurance company wants it to mean.”

Frank became an acolyte on the spot. She followed all Todd’s instructions — even when Todd told her they would wait until a week before her daughter’s surgery date to start working on the appeal.

That is part of Todd’s strategy. If you file an appeal months in advance, it becomes just another pile of paper caught in bureaucratic purgatory. It’s shuffled from one desk to another. The stakes are low.

Wait until you’re down to the wire, though, and your story has drama.

Finding the 14 top targets

The first thing Todd does is to find 14 executives — the number is at once impressive, and also fits well on the cover page — that she can target with the appeal.

Some will be from the insurance company. Some will be from the patient’s employer, because most Americans have self-funded plans, which means that the employer is the one paying for the medical treatment. Then she includes a few “outside eyes”: usually members of the insurance company’s board of directors. She picks them carefully: “I’m not going to choose heads of financial institutions, money men. I like presidents of universities, because they might be a little more impartial.”

These will be the people who will receive the appeal. And the phone calls. And the follow-up phone calls.

When she sits down to write, Todd first lays out the facts of the illness, sparing little. She wrote, for instance, about the debilitating tics that wracked Frank’s daughter, from biting her mouth to losing control of her bowels.  She wrote of the social isolation caused by Tourette’s. And of the 28 prescription drugs that had been tried, many of which had powerful side effects but provided little help.

Todd then picks apart the insurer’s reason for denying coverage. In the Frank case, she mocked it for using  “the coy new insurance company phrase ‘Medical studies we have seen.’”

After scouring the research herself, she wrote, she believed the company “would be hard-pressed to produce these mysterious medical studies that show that deep brain stimulation is used to treat Tourette’s, but is not suitable for Samantha’s ‘circumstances.’”

Todd also digs through patient support chat rooms to find precedents: past cases in which the company has agreed to pay for this procedure.

She likes to send her appeals to the insurance company on Sunday afternoons. The next morning, she and her client start in on what she calls “the phone attack.”

“I’m behind the scenes directing the whole thing,” said Todd.

Frank couldn’t have asked for a better general. The insurance company capitulated, covering her daughter’s brain stimulation and the subsequent courses of antibiotics and follow-up surgeries. The treatment was a success.

“I never thought my daughter would ever be able to finish school, to learn to drive, let alone to have a date,” said Frank. “Now she has a part-time job, she’s a senior, she has a boyfriend, she’s a wonderful guitar player.”

“You have the right to independent medical review, but how good are you going to be at taking advantage of it if you’ve got cancer?”

Dustin Berger, attorney

 

Families like Frank’s could go to an attorney for help crafting their appeal. But “it’s not a lucrative thing for attorneys to do,” said David Trueman, a New York lawyer who taught medical law at Columbia. “It doesn’t fall within the traditional confines of health law. There aren’t a whole lot of us out there who do this.”

Patients can also demand an external review of their case. They have a fair shot at winning: In states that tabulate such statistics, a third to a half of insurance companies’ denials get overturned by external, independent review boards. But it’s hard to navigate that system alone.

“You have the right to independent medical review, but how good are you going to be at taking advantage of it if you’ve got cancer?” said Dustin Berger, an attorney in Wyoming who has written about health insurance appeals.

Every health system rations care one way or another. And some might say that a warrior like Todd is sucking the system dry. To her, that analysis is backwards: She believes she gets patients the treatments that have the best chance of working, instead of wasting their time — and the insurers’ money — on endless rounds of less effective interventions.

“People say, ‘The insurance companies might come and torch your car,’” said Todd, laughing. “But I’m the insurance company’s best friend. I’m saving them hundreds of thousands of dollars by finding the patient the best treatment for them.”

Many of Todd’s clients — she calls them “helpees” — have become friends, and they send a steady stream of other patients her way. Now, they are encouraging her to train a successor.

“She’s an older lady,” said Frank. “She’s in her 60s, working alone, and she’s not going to be around forever.”

 

“POSTER CHILD” for PROFITS OVER PT SAFETY ?


Cadden boasted of control over federal regulators

http://www.tennessean.com/story/news/2017/01/20/cadden-boasted-control-over-federal-regulators/96806082/

Many “pain docs” that deal with implanted pumps uses these compounding pharmacies for the medications that they put in those pumps… because there is only one FDA approved opiate approved for use in those implanted pumps INFUMORPH (Morphine).. but because they can add a Lidocaine type product – which provides little/no pain relief to the pt – they can legally justify having the medication for their pumps compounded… Not to mention that they can purchase those compounded medications for 10% -25% of the cost of the commercially available product.  Also, Medtronics – the company that makes most of the implanted pumps – has tested the stability of the commercial product at SIX MONTHS – and typically the compounding pharmacy will only stand behind their stability for 30-60 days… allowing the pain doc to be able to charge for refilling pumps for frequently than would otherwise be necessary using the commercially available  product.  Medications that are infused into the spinal fluid has not only have to be STERILE …but.. must be PRESERVATIVE FREE… thus the potential issues of stability.  And how do I know all of this.. because my wife has had an implanted pain pump for TEN YEARS and I walked her out of the first pain clinic because they REFUSED to even discuss using INFUMORPH in the pump they were planning on implanting in her…  Even though they knew I was a Pharmacist… I was told that it was a “liability issue” and a “BIG BOY ISSUE” and that I didn’t understand… that they used a compounding pharmacy some 700-800 miles away and that there was no discussion to options about what they used in the pump.  After the New England Compound Center horror story… the FDA inspected 28 such compounding pharmacies and all but ONE got a NON-COMPLIANCE LETTER .. including the one that this pain clinic used.  So much for me NOT UNDERSTANDING 🙂

Barry Cadden

BOSTON – The head of a now-defunct Framingham, Mass. drug compounding firm boasted to his sales staff that state and federal regulators didn’t know what they were doing and he had to educate them so they’d stop bothering him.

That was one of the messages Barry J. Cadden delivered to the sales staff for the New England Compounding Center in a series of taped training sessions in 2011 and 2012.

The tapes were played this week in U.S. District Court during Cadden’s trial on charges of racketeering and second-degree murder. The trial, which is expected to last several months, will end its second week of testimony Friday.

Cadden was the president and part owner of the drug compounding firm that has been blamed for a deadly 2012 fungal meningitis outbreak which sickened 778 patients, killing 76 of them.

The jurors who will decide Cadden’s fate also heard from a former pharmacy technician at NECC who described the atmosphere in the company clean or sterile rooms as “a locker room on steroids.”

Joseph Connelly testified that, despite claims that it tested all of its products before shipping them out, NECC did not do so for most of the time he worked there.

And even when an end-testing policy was finally initiated in 2012, Connelly said he was told the very next day to ship out an order without testing.

The Cadden training tape excerpts, which were introduced over the objections of his lawyers, show Cadden giving instructions to sales staffers of an affiliated firm, Medical Sales Management. Dressed in blue scrubs, Cadden’s sessions included a tutorial on the attempts by state and federal regulators to place scrutiny on his operations.

Stating that the Massachusetts Board of Pharmacy had issued NECC its first license, Cadden told the staffers, who were employed by Medical Sales Management, an affiliated firm, they are the ones who “hold my life in their hands.”

“They don’t want to deal with us,” Cadden said, adding “They don’t know what they are looking at. They were coming down here all the time. I had to educate them. Then they got to understand.”

He boasted that when complaints came in from other states, the Massachusetts Pharmacy Board just says, “Go away.”

He also boasted of turning back efforts by the U.S. Food and Drug Administration to inspect and regulate NECC.

“The FDA was trying to take over drug compounding,” he said, adding that they were calling compounders “the wolf in sheep’s clothing.”

The lack of either state or federal oversight of NECC prompted investigations both in Massachusetts and Washington, D.C. Ultimately, tighter regulation was imposed in the wake of the deadly outbreak.

Cadden told the staffers that NECC went way beyond regulatory requirements in the compounding of drugs.

“A lot of what we do is way above the standard,” Cadden said. He added, “As far as quality goes, we do it. We’re not selling jelly beans. We need to bat one thousand.”

He instructed the sales staffers to “drop those names” of NECC’s big customers when soliciting new business and to stress to potential hospital customers that buying from NECC would eliminate the risk of something going wrong in in-house operations.”

In his testimony, Connolly, the pharmacy technician, said it was difficult to raise safety concerns because any efforts would be rebuffed by his boss Glenn Chin.

Chin, like Cadden, is facing racketeering and second-degree murder charges. His trial will be held when Cadden’s is completed.

Connolly said when he raised concerns, they went nowhere.

With photos displayed by prosecutors, Connolly described rusted equipment, floor defects covered with plastic and tape, and a wide opening to non-sterile areas, all in the rooms that were supposed to be perfectly sterile.

He said that when spiders, flies and other insects appeared, he and other workers would spray them with alcohol.

Connolly said the air conditioning in the clean room area frequently failed, sending temperatures soaring especially in summer months. This, despite the fact that the some of the chemicals they were using were temperature-sensitive. He said one co-worker had to leave the area because he was getting faint.

He said that when the company’s regulatory problems heated up in 2012, they were ordered to stop making drugs and clean up the area because inspectors were coming.

On another occasion, he said a worker from a sister company, Ameridose, came into the clean room area with some drugs from that firm.

“You don’t see this,” Connolly said the Ameridose worker told him.

Connolly said there was a big increase in product being produced at NECC in the Spring of 2012. He said he warned that “something’s going to happen,” and that the company would get shut down.

NECC shuttered its doors for good in October of 2012, just a month after the deadly outbreak became public.

People who abuse substances… will always find something to abuse

Opioid alternative linked to spike in WV overdose deaths

Aug 6, 2016… I posted this: Gabapentin the next medication to become a “controlled substance” ?

I nothing else… bureaucrats/politicians are fairly predictable

A drug being touted as a safer alternative for treating pain than more powerful prescription opioids is contributing to an increasing number of overdose deaths in West Virginia.

The number of fatal overdoses related to the nerve-pain drug gabapentin — sold by Pfizer under the brand name Neurontin — jumped from three in 2010 to 109 in 2015.

The increase has prompted a West Virginia Board of Pharmacy committee to recommend making gabapentin a controlled substance in the state. That would allow the pharmacy board to track prescriptions for gabapentin.

“It’s showing up in cocktails of drugs that are showing up in overdose deaths,” said Mike Goff, a pharmacy board administrator who oversees the state’s drug-monitoring database.

Addicts mix the drug with opioids or muscle-relaxants and anti-anxiety medications. The combination creates a euphoric high and can cause an unintentional overdose.

“Sometimes, they have prescriptions for all of them,” Goff said.

Last year’s gabapentin-related overdose deaths are expected to eclipse the 2015 total. The fatalities are still being counted. Gabapentin overdoses have increased each year since 2010.

If state lawmakers pass a bill that makes gabapentin a controlled substance, pharmacies would have to report prescriptions for the drug, and the state could monitor the number of pills prescribed each year.

“Right now, we don’t know the volume of the drug,” Goff said.

Ohio started requiring pharmacies to report sales of gabapentin on Dec. 1.

The U.S. Food and Drug Administration has approved gabapentin to treat seizures and pain caused by shingles. Some veterinarians also use it to treat epilepsy and seizures in dogs and cats.

But a recent study — first reported by Pain News Network — found one out of five people taking the drug are using it illegally. More than half took it with an opioid and about a quarter with an opioid and a muscle-relaxant or anxiety medication such as Xanax, according to researchers at ARIA Diagnostics.

 

A separate report by IMS Health found prescriptions for gabapentin increased 42 percent over the past five years nationwide. The U.S. Centers for Disease Control and Prevention has promoted the drug as a safer alternative to prescription opioids.

The West Virginia pharmacy board spotlighted the increase in gabapentin-related overdose deaths in the agency’s annual report released last week.

Other trends cited in the report:

The number of controlled substances dispensed in West Virginia decreased by 12.7 million last year — and by 30 million over five years. The number of hydrocodone pills dispensed statewide dropped by nearly 4 million last year, while oxycodone doses decreased by 4.5 million.

The opioid painkiller tramadol has increased from less than 1 million pills in 2011 to 35.7 million last year. Tramadol has fewer federal restrictions than hydrocodone and oxycodone.

“It’s way less potential for abuse, way less diversion,” Goff said.

West Virginians seeing multiple doctors and frequenting multiple pharmacies over a short period of time — a practice called “doctor shopping” — decreased 75 percent during the past two years.

The pharmacy board sends letters to pharmacists and physicians about suspected doctor-shoppers.

“It’s not an accusatory letter,” Goff said. “It’s an informational letter.”

The number of health professionals who use the state’s controlled substance database has doubled during the past two years. Doctors tap the database to check patients’ past prescriptions.

In West Virginia, 731 people — a record number — fatally overdosed on drugs in 2015. The state Medical Examiner’s Office has counted 717 drug overdose deaths so far in 2016, but the number is expected to increase — and likely surpass the 2015 total — after the office finishes tallying last year’s overdose deaths. The official count should be completed by March.

Fentanyl and heroin are the leading causes of overdose deaths. Hydrocodone- and oxycodone-related overdoses were highest between 2007 and 2014.